primary follicle stage / mRNA alternative polyadenylation / mRNA splice site recognition / dosage compensation by inactivation of X chromosome / N6-methyladenosine-containing RNA reader activity / regulation of mRNA splicing, via spliceosome / regulation of alternative mRNA splicing, via spliceosome / post-transcriptional regulation of gene expression / mRNA export from nucleus / mRNA splicing, via spliceosome ...primary follicle stage / mRNA alternative polyadenylation / mRNA splice site recognition / dosage compensation by inactivation of X chromosome / N6-methyladenosine-containing RNA reader activity / regulation of mRNA splicing, via spliceosome / regulation of alternative mRNA splicing, via spliceosome / post-transcriptional regulation of gene expression / mRNA export from nucleus / mRNA splicing, via spliceosome / spermatogenesis / in utero embryonic development / nuclear body / nuclear speck / mRNA binding / RNA binding / nucleoplasm / nucleus 類似検索 - 分子機能
ph1033 like fold / ph1033 like domains / YTH domain containing protein / YTH domain / YT521-B-like domain / YTH domain profile. / Roll / Alpha Beta 類似検索 - ドメイン・相同性
AUTHOR STATED THAT T253S IS NOT A MUTATION BUT A CONFLICT IN UNP.
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
タイプ
1
1
1
2D 1H-15N HSQC
1
2
1
2D 1H-13C HSQC aliphatic
1
3
1
2D 1H-13C HSQC aromatic
1
4
3
2D 1H-1H TOCSY
1
5
3
2D 1H-1H NOESY
1
6
1
3DCBCA(CO)NH
1
7
1
3D HNCO
1
8
1
3D HNCA
1
9
1
3D HN(CA)CB
1
10
1
3DH(CCO)NH
1
11
1
3D 1H-15N NOESY
1
12
1
3D 1H-13C NOESY aliphatic
1
13
1
3D 1H-13C NOESY aromatic
1
14
3
2D 1H-13C HSQC aliphatic
1
15
3
2D 1H-13C HSQC aromatic
1
16
1
3DC(CO)NH
1
17
2
2D 1H -1H NOESY 13C F1-filtered F2-filtered
1
18
2
3D 1H-13C NOESY 13C F1-edited F3-filtered
1
19
1
2D 1H -1H NOESY 13C15N F2-filtered
-
試料調製
詳細
Solution-ID
内容
溶媒系
1
0.8 mM [U-99% 13C; U-99% 15N] protein_1, 0.8 mM RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3'), 25 mM sodium phosphate, 25 mM sodium chloride, 10 mM beta-mercaptoethanol, 90% H2O/10% D2O
90% H2O/10% D2O
2
0.8 mM [U-99% 13C; U-99% 15N] protein_1, 0.8 mM RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3'), 25 mM sodium phosphate, 25 mM sodium chloride, 10 mM beta-mercaptoethanol, 100% D2O
100% D2O
3
0.8 mM [U-99% 15N] protein_1, 0.8 mM RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3'), 25 mM sodium phosphate, 25 mM sodium chloride, 10 mM beta-mercaptoethanol, 100% D2O
100% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
0.8mM
entity_1-1
[U-99% 13C; U-99% 15N]
1
0.8mM
RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3')-2
1
25mM
sodium phosphate-3
1
25mM
sodium chloride-4
1
10mM
beta-mercaptoethanol-5
1
0.8mM
entity_1-6
[U-99% 13C; U-99% 15N]
2
0.8mM
RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3')-7
2
25mM
sodium phosphate-8
2
25mM
sodium chloride-9
2
10mM
beta-mercaptoethanol-10
2
0.8mM
entity_1-11
[U-99% 15N]
3
0.8mM
RNA (5'-R(*UP*GP*(6MZ)P*CP*AP*C)-3')-12
3
25mM
sodium phosphate-13
3
25mM
sodium chloride-14
3
10mM
beta-mercaptoethanol-15
3
試料状態
pH: 7 / 圧: ambient / 温度: 303 K
-
NMR測定
NMRスペクトロメーター
タイプ
製造業者
モデル
磁場強度 (MHz)
Spectrometer-ID
Bruker Avance
Bruker
AVANCE
900
1
Bruker Avance
Bruker
AVANCE
700
2
Bruker Avance
Bruker
AVANCE
600
3
Bruker Avance
Bruker
AVANCE
500
4
-
解析
NMR software
名称
開発者
分類
Sparky
Goddard
chemicalshiftassignment
TALOS
Cornilescu, DelaglioandBax
データ解析
TopSpin
BrukerBiospin
collection
TopSpin
BrukerBiospin
解析
CYANA
Guntert, MumenthalerandWuthrich
構造決定
Amber
Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... andKollman
精密化
精密化
手法: simulated annealing / ソフトェア番号: 1
代表構造
選択基準: lowest energy
NMRアンサンブル
コンフォーマー選択の基準: structures with the lowest energy 計算したコンフォーマーの数: 50 / 登録したコンフォーマーの数: 20 / 代表コンフォーマー: 1